Search

Novartis AG

Lezárt

161.91 -1.83

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

163.22

Maximum

165.84

Fő mutatók

By Trading Economics

Bevétel

-2.1B

1.2B

Értékesítés

611M

15B

P/E

Szektor átlag

30.824

51.78

Egy részvényre jutó nyereség

2.46

Osztalékhozam

2.93

Profit margin

7.958

Munkavállalók

75,267

EBITDA

-571M

5.4B

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

-3.22% downside

Osztalékok

By Acuity

Osztalékhozam

Szektor átlag

2.93%

1.96%

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

13B

305B

Előző nyitás

163.74

Előző zárás

161.91

Novartis AG Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. nov. 4. 23:56 UTC

KBR Inc shares are down significantly in after-market trading, falling to their lowest point of the day.

2026. nov. 4. 23:56 UTC

News
Social Media

Trimble Inc appoints Matthew C. Brown, former CFO of Tenable Holdings, to its Board of Directors in after-market trading.

2026. nov. 4. 23:56 UTC

Correlated Moves

D.R. Horton, Inc. shares traded modestly lower in after-market hours, while Amcor PLC's sharp decline followed disappointing Q1 results and lowered EPS guidance.

2026. nov. 4. 23:56 UTC

Hims & Hers Health, Inc. is trading modestly higher in after-market hours following an increase during the session.

2026. nov. 4. 23:56 UTC

Correlated Moves

Lattice Semiconductor Corporation shares declined in after-market trading, continuing a downward trend since Wednesday's close and nearing the lower end of their one-month range.

2026. nov. 4. 23:56 UTC

IES Holdings Inc shares rose significantly during after-market hours on Wednesday, recovering from a recent decline and moving higher following the close of regular trading.

2026. nov. 4. 23:56 UTC

Synopsys, Inc. shares are trading modestly higher in after-market hours, recovering from earlier lows after four consecutive daily declines.

2026. nov. 4. 23:52 UTC

News

Uranium Energy Corp. is trading modestly higher in after-market hours following fluctuations since Wednesday's close.

2026. nov. 4. 23:51 UTC

Kontoor Brands, Inc. is trading lower in after-market hours, retreating from a brief uptick and remaining at the lower end of its recent range.

2026. nov. 4. 23:51 UTC

GE HealthCare Technologies Inc. is trading modestly higher in after-market hours, despite a slight decline from earlier session highs.

2026. nov. 4. 23:51 UTC

Mondelez International, Inc. shares have advanced modestly in after-market hours, remaining near the upper end of their one-month range.

2026. nov. 4. 23:51 UTC

Avient Corp is declining in after-market trading, falling to its lowest point of the day.

2026. nov. 4. 23:51 UTC

Lindsay Corporation's shares traded modestly lower during after-market hours on Wednesday, remaining around the midpoint of their one-month trading range.

2026. nov. 4. 23:51 UTC

News

Watts Water Technologies reports Q3 net sales of $728 million, exceeding estimates, with diluted EPS of $4.34 and raises full-year sales growth outlook to 17%-18%.

2026. nov. 4. 23:51 UTC

Twist Bioscience Corporation shares declined during after-market hours on Wednesday, reversing a trend of higher daily closes observed in recent sessions.

2026. nov. 4. 23:51 UTC

Wendy's Co shares are declining in after-market trading, reflecting pronounced losses despite a strong recent performance and seven consecutive sessions of higher closes.

2026. nov. 4. 23:51 UTC

Delta Air Lines, Inc. shares are trading lower in after-market hours, pulling back from earlier gains.

2026. nov. 4. 23:51 UTC

Correlated Moves

Clorox Company shares are modestly lower in after-market trading, following a brief peak earlier in the session.

2026. nov. 4. 23:51 UTC

BlackRock, Inc. shares traded modestly lower in after-market hours, retracing from an early session peak.

2026. nov. 4. 23:51 UTC

Correlated Moves

Vertiv Holdings Co is modestly higher in after-market trading, moving in sympathy with Eaton Corporation PLC following strong third-quarter results.

2026. nov. 4. 23:51 UTC

Redwood Trust, Inc. shares declined during after-market trading on Wednesday, moving notably lower from a modest high shortly after the market closed.

2026. nov. 4. 23:46 UTC

News
Correlated Moves

Chord Energy reports Q3 adjusted EPS of $6.08, exceeding estimates, while revenues of $1.71B missed expectations; raises 2026 adjusted EBITDA guidance to $3.4B.

2026. nov. 4. 23:46 UTC

Martin Marietta Materials, Inc. is trading modestly higher in after-market hours, reaching its highest level since Wednesday's close and above its 20-day moving average.

2026. nov. 4. 23:46 UTC

ZIM Integrated Shipping Services Ltd is trading lower in after-market hours, continuing its downward trend from Wednesday's close and positioned 3.49% below its 20-day moving average.

2026. nov. 4. 23:46 UTC

News

UBS maintains Neutral rating on Coca-Cola Europacific Partners PLC and raises price target to $115 in a report published after the market closed.

2026. nov. 4. 23:46 UTC

The NZD/CAD is trading modestly higher, supported by stronger-than-expected ADP Employment Change data, which reported an increase of 86k jobs in October.

2026. nov. 4. 23:46 UTC

GBP/NZD is lower, reflecting a decline since Tuesday's close.S. employment and services data.

2026. nov. 4. 23:46 UTC

Arbor Realty Trust, Inc. traded roughly flat in after-market hours, remaining near the lower end of its one-month range and below its 20-day moving average.

2026. nov. 4. 23:42 UTC

Lincoln Electric Holdings, Inc. is trading lower in after-market hours, reversing an initial gain and marking a fourth consecutive daily decline.

2026. nov. 4. 23:42 UTC

Alector, Inc. is declining sharply in after-market trading, reaching its lowest point of the day after previously showing strength above its 20-day moving average.

Társak összehasonlítása

Árváltozás

Novartis AG Előrejelzés

Célár

By TipRanks

-3.22% elmozdulás lefelé

12 hónapos előrejelzés

Átlag 159.667 USD  -3.22%

Magas 180 USD

Alacsony 136 USD

4 Wall Street elemző 12 hónapos célárain alapulva a(z)Novartis AG termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

4 ratings

2

Vétel

2

Tartás

0

Eladás

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Novartis AG

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. The company also provides Pluvicto, lutetium Lu 177 vipivotide tetraxetan, indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer; and Lutathera, lutetium Lu 177 dotatate, a prescription medicine used to treat adults and children aged 12 years and older with gastroenteropancreatic neuroendocrine tumors. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. The company has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. It also has a research collaboration and license agreement with Schrödinger, Inc. to identify and develop various therapeutic candidates; and a strategic collaboration with Vyriad, Inc. for the discovery and development for vivo chimeric antigen receptor T-cell therapies. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
help-icon Live chat